Z
Zhiding Medical Technology (Hangzhou)
A leading producer of optical medical equipment in China
About Zhiding Medical Technology (Hangzhou)
Zhiding Medical Technology (Hangzhou) Co., Ltd. is a Chinese high-tech enterprise focused on the research, development, manufacturing, and sales of high-precision optical medical equipment, particularly in the field of ophthalmology. The company was initially established in Nanjing in 2012, specializing in vein visualization products. In 2015, the headquarters were relocated to Hangzhou, a move that marked a strategic pivot towards comprehensive ophthalmic solutions. Zhiding Medical was founded by a group of overseas professors and brings together experts in optics and precision machinery from both China and the United States. The founder, Dr. Tang Lei, has been actively involved in discussions on medical equipment innovation and cooperation.
The company's business model revolves around the direct sale of its proprietary medical devices to healthcare providers worldwide. Its client base includes hospitals and specialized eye clinics. Zhiding Medical operates in the high-tech medical device market, with a significant emphasis on ophthalmology. Key milestones for the company include developing China's first ophthalmic Optical Coherence Tomography Angiography (OCTA) in 2016, obtaining National Class II medical machinery production licenses in 2017, and launching its widely acclaimed OCTA/OCT products in 2018. Between 2019 and 2022, the firm established the Zhiding Cloud Film Reading Center for remote OCT assistance, secured multiple rounds of funding, and entered into strategic cooperations with Lumenis and the Suzhou Institute of Biomedical Engineering Technology. In the third quarter of 2022, the company successfully completed a 50 million RMB Series B financing round.
Zhiding Medical's product portfolio addresses critical needs in diagnostics and treatment. Its core offerings include Optical Coherence Tomography (OCT) and OCTA scanners, which provide non-invasive, high-resolution imaging of retinal structures to diagnose fundus diseases. Another major focus is on dry eye disease, for which the company manufactures a comprehensive suite of products including the D500 and D600 Dry Eye Analyzers/Detectors. These devices assist in diagnosing Meibomian Gland Dysfunction (MGD) by capturing clear images of the glands and tear film. For treatment, Zhiding offers an Intense Pulsed Light (IPL) therapy system and an Atomizing Fumigator, which uses a heated, atomized mist to moisturize the eyes. The company also continues to produce its original vein visualization systems, which use infrared light to help with venipuncture.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 22
- Open positions
- None listed
- Dealroom signal
- 26.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Ophthalmology, Medical Imaging, Health Diagnostics, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Nov 2024 | $14M | $55M | Hyfinity Investments · Hankang Capital · Med-Fine Capital · Sunmed Capital | ↗ |
| SERIES AEquity / VC | Jun 2019 | $4.3M | $17M | Qiming Venture Partners | — |
Growth signals
Latest recorded traffic for Zhiding Medical Technology (Hangzhou) is 400 monthly website visits, down 59.6% over the last three months. Zhiding Medical Technology (Hangzhou)'s team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Zhiding Medical Technology (Hangzhou) in the Hangzhou ecosystem
The Zhiding Medical Technology (Hangzhou) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later4 investors entered at this stage
Hyfinity Investments
Hankang Capital
Med-Fine Capital
Sunmed Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zhiding Medical Technology (Hangzhou) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zhiding Medical Technology (Hangzhou)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









